Metabolic Profile of Users of Hormonal and Non-hormonal Contraceptives
NCT ID: NCT03383185
Last Updated: 2017-12-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
489 participants
OBSERVATIONAL
2010-01-01
2015-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The contraceptive methods available were the intrauterine device (IUD) oral contraceptives, including combined pills and progestin-only formulations, and depot medroxyprogestereone acetate.
The study consisted in the evaluation of their medical records of weight, BMI, Blood pressure, glycemia, seric levels of cholesterol and triglycerides, during the five years, and in the comparison of the differences of these data between the contraceptive methods.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-hormonal contraceptive
Users of non- hormonal intrauterine device during the 5 years follow-up
Intrauterine device
Use of Intrauterine device during the follow-up period
Hormonal contraceptives
Users of combined oral contraceptive, progestin-only pills, depot-medroxyprogestereone acetate during 5 years follow-up
Combined Oral Contraceptive
Use of combined oral contraceptive during the follow-up period
Progestin-only pills
Use of progestin-only pills during the follow-up period
Depot-Medroxyprogestereone Acetate
Use of depot-medroxyprogesterone acetato during the follow-up period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intrauterine device
Use of Intrauterine device during the follow-up period
Combined Oral Contraceptive
Use of combined oral contraceptive during the follow-up period
Progestin-only pills
Use of progestin-only pills during the follow-up period
Depot-Medroxyprogestereone Acetate
Use of depot-medroxyprogesterone acetato during the follow-up period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* use of the same contraceptive method during five years
Exclusion Criteria
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ana Maria Homem de Mello Bianchi
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Sao Paulo - Unifesp
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAAE: 45523715.4.0000.5505
Identifier Type: -
Identifier Source: org_study_id